m+Medelevator.RU
← Поиск публикаций
Genetics in medicine : official journal of the American College of Medical Genetics · 2018

Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients.

СтатьяResearch Support, N.I.H., IntramuralПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Calsina Bruna, Currás-Freixes Maria, Buffet Alexandre, Pons Tirso, Contreras Laura, Letón Rocío, Comino-Méndez Iñaki, Remacha Laura, Calatayud María, Obispo Berta, Martin Antoine, Cohen Regis, Richter Susan, Balmaña Judith, Korpershoek Esther, Rapizzi Elena, Deutschbein Timo, Vroonen Laurent, Favier Judith, de Krijger Ronald R, Fassnacht Martin, Beuschlein Felix, Timmers Henri J, Eisenhofer Graeme, Mannelli Massimo, Pacak Karel, Satrústegui Jorgina, Rodríguez-Antona Cristina, Amar Laurence, Cascón Alberto, Dölker Nicole, Gimenez-Roqueplo Anne-Paule, Robledo Mercedes

Аннотация

PURPOSE: MDH2 (malate dehydrogenase 2) has recently been proposed as a novel potential pheochromocytoma/paraganglioma (PPGL) susceptibility gene, but its role in the disease has not been addressed. This study aimed to determine the prevalence of MDH2 pathogenic variants among PPGL patients and determine the associated phenotype.

METHODS: Eight hundred thirty patients with PPGLs, negative for the main PPGL driver genes, were included in the study. Interpretation of variants of unknown significance (VUS) was performed using an algorithm based on 20 computational predictions, by implementing cell-based enzymatic and immunofluorescence assays, and/or by using a molecular dynamics simulation approach.

RESULTS: Five variants with potential involvement in pathogenicity were identified: three missense (p.Arg104Gly, p.Val160Met and p.Ala256Thr), one in-frame deletion (p.Lys314del), and a splice-site variant (c.429+1G>T). All were germline and those with available biochemical data, corresponded to noradrenergic PPGL.

CONCLUSION: This study suggests that MDH2 pathogenic variants may play a role in PPGL susceptibility and that they might be responsible for less than 1% of PPGLs in patients without pathogenic variants in other major PPGL driver genes, a prevalence similar to the one recently described for other PPGL genes. However, more epidemiological data are needed to recommend MDH2 testing in patients negative for other major PPGL genes.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты